CDK6 and glioblastoma: Based on what is known regarding the regulation of E2F transcription factors [50], we decided to test if the previously identified Msi1 direct targets CDK6, CDKN1A/p21, CDKN1B/p27 [3,21,24,53] affect E2F2 and E2F8 levels in glioblastoma cells.